Sierra Oncology

+$1.50 (+6.00%) Today

-$0.12 (-0.45%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRRA and other ETFs, options, and stocks.

About SRRA

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology.

CEO

Stephen George Dilly

Employees

Headquarters

Vancouver, British Columbia

Founded

2003

SRRA Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

5.88M

High today

$27.44

Low today

$24.75

Open price

$25.61

Volume

1.90M

52 Week high

$29.48

52 Week low

$13.68

SRRA News

Simply Wall StJan 25

What Kind Of Investors Own Most Of Sierra Oncology, Inc.?

A look at the shareholders of Sierra Oncology, Inc. (NASDAQ:SRRA) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller

MarketWatchJan 25

Sierra Oncology Gets Loan to Support Myelofibrosis Drug Potential Rollout Following Positive Results

By Kimberly Chin Sierra Oncology Inc. said it has secured a term loan with Oxford Finance LLC that will mostly support the commercial preparation and potential

ReutersJan 25

Sierra Oncology's bone marrow cancer drug meets study main goal

Jan 25 (Reuters) - Sierra Oncology Inc (SRRA.O) said on Tuesday its experimental drug for anemic patients with a type of bone marrow cancer met the main goal of

SRRA Earnings

-$1.86

-$1.24

-$0.62

-$0.00

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Mar 10, Pre-Market

Why Robinhood?

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. View more

What Kind Of Investors Own Most Of Sierra Oncology, Inc.?

Sierra Oncology Gets Loan to Support Myelofibrosis Drug Potential Rollout Following Positive Results

Sierra Oncology's bone marrow cancer drug meets study main goal

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology.